Highlights
NASDAQ: NVUS       Novus Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
0.462   +0.007 (1.54%)  0.43 - 0.47  540,900

Overview

 
Avg Volume (4 weeks):987,952
4 Weeks Range:0.42 - 0.65
4 Weeks Price Volatility (%):
18.26%
52 Weeks Range:0.25 - 1.45
52 Weeks Price Volatility (%):
17.67%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Novus Therapeutics Inc is engaged in the biotechnology sector. As a pharmaceutical company, it is focused on the acquisition, development, and commercialization of ear, nose, and throat related products. It has two platforms: OP-01 Foam Platform and OP-02 Surfactant Program. OP-01 is developed with the intent to be used as a delivery vehicle for drugs treating ears, as well as the nasal and sinus cavities. OP-02 is being developed as a potential treatment option for patients with otitis media and Eustachian tube dysfunction.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2452  5804  513  138 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ZOM 0.168-0.057 
 GNUS 3.55+1.24 
 NIO 9.38+1.47 
 LK 1.38-1.62 
 SOLO 3.13+0.80 
 WKHS 20.91+1.73 
 AAL 12.50-0.31 
 JOB 1.50+0.986 
 SQQQ 7.14-0.15 
 GE 6.82+0.08 
Partners & Brokers